Overview
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
Eligibility
Inclusion Criteria:
- Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty
Exclusion Criteria:
- Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.


